We are live on ! Find out more
JC

JBF Capital Portfolio holdings

AUM $764M
1-Year Est. Return 24.26%
This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+24.26%
3 Year Est. Return
+93.63%
5 Year Est. Return
+127.41%
10 Year Est. Return
+469.69%
AUM
$664M
AUM Growth
+$30.9M
Cap. Flow
+$15M
Cap. Flow %
2.26%
Top 10 Hldgs %
86.89%
Holding
104
New
21
Increased
17
Reduced
11
Closed
16

Sector Composition

Rank Sector Weight
1 Financials 8.06%
2 Consumer Discretionary 5.62%
3 Technology 5.16%
4 Healthcare 3.57%
5 Communication Services 1.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARGX icon
26
argenx
ARGX
$53.6B
$1.74M 0.26%
20,990
-5,000
-19% -$447K
CLLS
27
Cellectis
CLLS
$320M
$1.7M 0.26%
+60,000
New +$1.79M
BPRN icon
28
Princeton Bancorp
BPRN
$296M
$1.66M 0.25%
50,000
CPRX
29
DELISTED
Catalyst Pharmaceutical
CPRX
$1.59M 0.24%
508,600
+50,000
+11% +$152K
CCT
30
DELISTED
Corporate Capital Trust, Inc.
CCT
$1.56M 0.24%
+100,000
New +$1.66M
AAPL icon
31
CALL
Apple
AAPL
$4.46T
$1.5M 0.23%
4,000
BPMC
32
DELISTED
Blueprint Medicines
BPMC
$1.42M 0.21%
22,322
+11,500
+106% +$915K
GCAP
33
DELISTED
Gain Capital Holdings, Inc.
GCAP
$1.33M 0.2%
176,800
VXX
34
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$1.32M 0.2%
35,590
-14,410
-29% -$557K
CHRD icon
35
Chord Energy
CHRD
$7.35B
$1.3M 0.2%
100,000
-500,000
-83% -$5.69M
BXC icon
36
BlueLinx
BXC
$705M
$1.2M 0.18%
31,900
+4,000
+14% +$156K
BOLD
37
DELISTED
Audentes Therapeutics, Inc
BOLD
$1.2M 0.18%
31,300
+10,000
+47% +$370K
RDI icon
38
Reading International Class A
RDI
$33.2M
$1.19M 0.18%
74,325
AMRWW
39
CALL
DELISTED
Alta Mesa Resources Inc Warrant
AMRWW
$1.04M 0.16%
740,832
FSACU
40
DELISTED
Federal Street Acquisition Corp. Unit
FSACU
$1.01M 0.15%
100,000
BMRN icon
41
BioMarin Pharmaceuticals
BMRN
$13.3B
$995K 0.15%
10,560
-2,000
-16% -$175K
MR
42
DELISTED
Montage Resources Corporation Common Stock
MR
$980K 0.15%
40,825
EIRL icon
43
iShares MSCI Ireland ETF
EIRL
$78.8M
$919K 0.14%
19,411
KYNB
44
Kyntra Bio
KYNB
$28.5M
$883K 0.13%
564
+200
+55% +$261K
BMY icon
45
Bristol-Myers Squibb
BMY
$132B
$863K 0.13%
15,600
+5,000
+47% +$270K
DIS icon
46
Walt Disney
DIS
$181B
$744K 0.11%
7,100
IRL
47
DELISTED
NEW IRELAND FUND INC
IRL
$702K 0.11%
60,100
CET
48
Central Securities Corp
CET
$1.63B
$697K 0.11%
25,000
GBT
49
DELISTED
Global Blood Therapeutics, Inc.
GBT
$678K 0.1%
+15,000
New +$683K
XNCR icon
50
Xencor
XNCR
$1.71B
$625K 0.09%
16,900

Similar funds

JBF Capital's Q2 2018 Portfolio in Review

As of Q2 2018, JBF Capital held 104 positions worth $664M, up 4.9% from $633M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

JBF Capital's Q2 2018 filing shows 21 new, 17 increased, 11 reduced and 16 closed positions. Its largest new stake was Tesla: 578,010 shares worth $13.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $12.1M.

By sector, the portfolio is most concentrated in Financials at 8.1% of assets, up from 6.7% a quarter earlier, followed by Consumer Discretionary and Technology.

  • JBF Capital's largest Q2 2018 buy was Tesla: 578,010 shares worth $13.2M.
  • JBF Capital added most to Microsoft in Q2 2018, an estimated $4.85M increase.
  • JBF Capital's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $12.1M.
  • JBF Capital fully exited GE Aerospace in Q2 2018, selling an estimated $5.39M.
  • JBF Capital's ten largest holdings make up 87% of its $664M portfolio in Q2 2018.
  • JBF Capital opened 21 new positions and closed 16 in Q2 2018.
  • JBF Capital's portfolio value rose 4.9% quarter-over-quarter to $664M.

Based on JBF Capital's 13F filing for Q2 2018, filed 9 Aug 2018.